ANTHONY B. EVNIN - 16 Jun 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Director
Signature
/s/Seth A. Tasker as attorney-in-fact for Anthony B. Evnin
Issuer symbol
N/A
Transactions as of
16 Jun 2022
Net transactions value
+$31,491
Form type
4
Filing time
16 Jun 2022, 21:29:24 UTC
Previous filing
08 Jun 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INFI Common Stock Award $31,491 +46,378 +27% $0.6790* 215,403 16 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option(right to buy) Award $0 +45,000 $0.000000 45,000 16 Jun 2022 Common Stock 45,000 $0.6790 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the issuer's non-employee director compensation program, the reporting person has elected to receive this grant of shares in lieu of cash as payment of approximately 75% of such person's $42,000 annual retainer for service as a director.
F2 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.

Remarks:

Exhibit 24 - Limited Power of Attorney